2.29.2008

No Additional Benefit Found for Personalized Intervention to Promote Regular Mammography Screening

Two different interventions did not significantly increase regular mammography screening in a large randomized study.

Behavioral interventions, such as personalized mailings, have been reported to increase one-time cancer screening. However, few studies have examined the impact of behavioral interventions on regular or on-going participation in screening exams.

Sally Vernon, Ph.D., of the University of Texas School of Public Health in Houston and colleagues assigned 5,500 female veterans to one of three interventions designed to encourage annual mammograms - a baseline survey plus a targeted mailing, a baseline survey plus a targeted mailing that was tailored to individual participants, or the baseline survey alone. The investigators then looked to see how many women in each group had completed two mammograms as recommended during the three-year follow-up period.

source: MedicalNewsToday adapted from the Journal of the National Cancer Institute

2.28.2008

iCAD Introduces Next Generation TotalLook Film Digitizer

iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early detection of cancer, today announced the availability of the TotalLook MammoAdvantage system which converts prior mammography films to digital images for comparative review on a single digital review workstation. This new version of iCAD’s state-of-the-art film digitizing solution offers improved image quality, enhanced image customization options and workflow efficiency features.

TotalLook MammoAdvantage’s new DigitalLook and PremiumLook image outputs closely match digital mammography images offering enhanced tissue visualization, higher contrast and better edge definition to improve comparative reading. TotalLook MammoAdvantage’s unique software offers configurable image resolution settings that display the digitized images at the same resolution as the digital mammography images, enabling the digitized and newly acquired digital images to be displayed at the same size.

source: iCAD

How Accurate Is Your Mammogram Reading?

(NaturalNews) The National Breast Cancer Surveillance Consortium recently published a disturbing in-depth study claiming that the ability of the radiologist who reads mammograms will greatly affect the accuracy of the result. "Obviously when a woman has a mammogram she wants to know if she has breast cancer" said study leader Diana Miglioretti, PhD an associate investigator, "especially if the woman has a breast concern". Ideally, the study claims there should be a uniformity which wouldn't depend entirely on the ability of the radiologist.

This in-depth research, covered by three universities, tested 123 radiologists and interpreted nearly 36,000 diagnostic mammograms. Different radiologists reported different results, ranging from 27 percent to 100 percent, with false positives up to 16 percent indicating there are obvious problems.

from article by Michael Cambray for Natural News.com

2.27.2008

CT Laser Mammography Technology to be Featured at Interdisciplinary Breast Cancer Conference

FORT LAUDERDALE, Fla., Feb. 27 /PRNewswire-FirstCall/ --
Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS)
a pioneer in laser optical breast imaging systems, will exhibit
CT Laser Mammography (CTLM(R)) technology at the 18th Annual
National Interdisciplinary Breast Cancer Conference, March 1-5,
in Las Vegas, Nevada. IDSI will be located at booth #43.

"Attending the 18th Annual National Interdisciplinary Breast
Cancer Conference is important for IDSI," explained Deborah
O'Brien, IDSI Senior Vice President. "It grants us the opportunity
to meet with the medical professionals who will be working with
CTLM in the future, to educate them on how our technology fits
into an interdisciplinary approach to managing the treatment of
breast cancer. We are able to meet with the physicians and
technologists who are working with CTLM in our clinical trials
and to allow them to discuss their experiences with us and with
those who are unfamiliar with laser breast imaging."

source: PR Newswire

Homeless Women get Mammograms at Project Homeless Connect

For women who lack a home or a safe place to stay, getting a regular mammogram is probably way down on their list of things to do. They are too busy struggling just to survive. But now California Pacific Medical Center is providing free mammograms and a full health care check-up for some homeless women at the Project Homeless Connect on February 27th at the Bill Graham Civic Auditorium.

"These women have already endured so much," says Shirley Manly Lampkin, R.N., Ph.D., Director of California Pacific Medical Center's Community Benefits program. "That's why we want to help them in whatever way we can, by offering them a complete health assessment, in a way that makes them feel cared for, and respected."

source: medicexchange.com

2.26.2008

Study: Mammogram Reminders Not Helpful

Feb. 26, 2008 -- Women who are due for a mammogram may want to go ahead and schedule their appointment and not wait on the reminder letter from their doctor.

A new study shows that those reminder letters may not boost mammography rates.

The study included 8,444 female veterans aged 52 and older covered by the VA system.

source: WebMD

Three Year Analysis Of Treatment Efficacy, Cosmesis, And Toxicity Support Use Of The Hologic Mammosite Radiation Therapy System

Hologic, Inc. (Nasdaq: HOLX) a diversified medical technologies company specializing in imaging systems, diagnostics, and interventional devices dedicated to serving the healthcare needs of women, announced the publication of a study evaluating the Hologic MammoSite(R) Radiation Therapy System (RTS), one-, two- and three-years after treatment. The study by Frank A. Vicini, M.D., and others, published in the February 15, 2008, issue of Cancer(1), the peer- reviewed professional journal of the American Cancer Society, reports on treatment efficacy, cosmetic results and toxicities of patients enrolled in the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial.

The American Society of Breast Surgeons MammoSite Registry(2) includes a total of 1,440 patients with early stage breast cancer, who were undergoing breast-conserving therapy and were treated with MammoSite RTS between May 2002 and July 2004. Of the total, 87 percent of the patients had invasive breast cancer and 13 percent had been diagnosed with ductal carcinoma in situ (DCIS).

source: Medical News Today

2.25.2008

HRT Can Lead to Abnormal Mammograms, Biopsies

By Amanda Gardner
HealthDay Reporter


MONDAY, Feb. 25 (HealthDay News) -- Women who take combined hormone therapy for about five years have a higher risk of abnormal mammograms and breast biopsies.

This, in turn, may decrease the effectiveness of these methods of detecting breast cancer, according to a new study published in the Feb. 25 issue of Archives of Internal Medicine.

"Women need to be aware of the risks, and it's not just risk of increased breast cancer. It's a risk of possibly having abnormal mammograms and really being tortured by them," said Dr. Kristin Byrne, chief of breast imaging at Lenox Hill Hospital in New York City, who was not involved with the study. "It's a whole slew of things they need to be aware of before making a decision to go on hormone therapy."

source article: Yahoo News

Examine : Mammography: In Pursuit of Perfection

Laurie Margolies, MD, assistant professor of radiology at Mount Sinai School of Medicine and director of breast imaging at Mount Sinai Hospital, both in New York City, discusses some of the recently published studies that conclude that mammogram interpretation is dependent upon the training and skill level of the radiologist reading the image and their access to other modalities and technologies.

There’s no doubt that we’ve made great strides in detecting breast cancer with mammograms – early detection resulting from the increase in women receiving regular mammograms is believed to be largely responsible for the dramatic rise in breast cancer survival rates.

However, the importance of training and access to technology cannot be understated in order to achieve even higher ratings of screening accuracy. Both of these issues have recently been discussed in major medical journals.

read complete article at RT-Image

2.21.2008

Breast X-Rays May Predict Stroke Risk

Charlene Laino
WebMD News

Feb. 21, 2008 (New Orleans) -- Mammograms may help predict whether a woman is at increased risk for stroke, new research suggests.

That because breast X-rays can spot benign calcium deposits in the arteries, says Paul S. Dale, MD, chief of surgical oncology at the University of Missouri's Ellis Fischel Cancer Center in Columbia.

The presence or absence of calcium is related to the degree of plaque buildup in the arteries, he says. And plaque buildup, or atherosclerosis, in the arteries leading to the brain is a major cause of stroke.

source: Web MD Copyright © 2005 - 2007, WebMD, Inc. All rights reserved

FUJIFILM's Digital Mammography Technology Now Available for Mobile Use

STAMFORD, Conn., Feb. 21 /PRNewswire/ -- FUJIFILM Medical
Systems USA,Inc.'s Computed Radiography for Mammography
(FCRm), the world's most widelyused Full Field Digital
Mammography (FFDM) system, is now available for use in
mobile mammography environments. The first two
installations of Mobile FCRm systems were in mobile units
by the Harris County Hospital District in Houston
and St. Joseph's Hospital of Atlanta.


"Just as the U.S. adoption of FCRm by traditional breast
imaging facilities has been mirroring our worldwide success
with record sales, we expect the U.S. mobile mammography market
to also mirror our international success with Mobile FCRm,"
Andrew Vandergrift, National Marketing Manager, Women's Healthcare
Imaging, FUJIFILM Medical Systems USA. "We believe that
Fujifilm has the ideal solution to enable mobile mammography
providers to readily implement FFDM and broaden the availability
of digital mammography".

PR Newswire

2.20.2008

ART Announces First Sale of SoftScan Optical Breast Imaging System

MONTREAL, CANADA--(Marketwire - Feb. 20, 2008) - ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce the first sale of its SoftScan® optical breast imaging system to the Sunnybrook Health Sciences Centre ('Sunnybrook") in Toronto, Canada. Sunnybrook is the first health centre to purchase a SoftScan imaging system since ART received regulatory approval from Health Canada for the commercialization of its optical breast imaging device.

Dr. Gregory Czarnota, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, and Scientist in Imaging Research at Sunnybrook Research Institute, is the principal investigator of a pilot study to determine the role for the SoftScan system in monitoring response to treatment of breast cancer, particularly neoadjuvant therapies. He works with Dr. Martin Yaffe, Senior Scientist in Imaging Research at Sunnybrook Research Institute, in advancing this programme.

source: Marketwire.com

2.18.2008

Breast Care Solutions by Siemens offer a comprehensive product spectrum for diagnosis and therapy

Among women, breast cancer is the most common cause of cancer death. Each year nearly 180,000 women in the United States are diagnosed with breast cancer. More than 40,000 a year die from this disease*. These facts stress the importance of a quality-ensured early detection of breast cancer as well as the availability of individual therapies. In response, Siemens Healthcare developed comprehensive Breast Care Solutions for the early detection and treatment of breast cancer. These combine different imaging methods, such as ultrasound, mammography, and magnetic resonance tomography (MRT), which are supplemented by innovative software tools and solutions from lab diagnostics.

This multi-modality approach in breast medicine is increasingly gaining the acceptance of physicians. Imaging methods, such as MRT and Ultrasound, are becoming more and more important. All imaging methods in breast medicine enable comprehensive early detection and after-care. The advantages of the new technologies include improved image quality and optimized workflows that support the physician in his work. In turn more patients can be examined within a shorter period of time. Immuno-diagnostic tests provide information about the course of therapy.

source: Siemens

Breast Cancer Blood Test Introduced to the Middle East

The most prevalent cancer among women, breast cancer affects approximately 1.2 million women worldwide. While millions of American women receive mammography screenings each year, many women in the Middle East avoid this important screening procedure, often because of strong underlying cultural bias.

"Fully 70% of worldwide breast cancer cases occur in developing countries," says Dr. Essam Sheta, a researcher at Power3 Medical Products, Inc. (OTCBB: PWRM), a company specializing in the development and commercialization of diagnostic tests for the early detection of breast cancer and neurodegenerative diseases. "Lack of early detection and diagnosis is the basis for this high incidence rate. While in the U.S., doctors use mammography, ultrasound, and MRI to diagnosis women with breast cancer, these procedures are available, but scarce in developing countries."

read article at centredaily.com

2.17.2008

Benefits Of Medicare Paid Mammography Lag For Black Women

Randy Dotinga

When Medicare began paying for older women to undergo preventive mammograms in 1991, doctors expected breast cancer mortality rates to drop. Breast cancer deaths did decrease, but new research has unveiled a discrepancy: African American women as a group do not benefit as much as white women.

Breast cancer death rates for the two ethnic groups used to be nearly identical.

"It looks like the implementation of the Medicare benefit did a lot of good, but the benefits may not have accrued to everyone equally. White (death) rates declined faster," said study lead author Dr. Robert Levine, professor in the family and community medicine department at Meharry Medical College in Nashville, Tenn.

source - Center for the Advancement of Health

2.16.2008

Deadly disparity in cancer detection

Dr. Syed Ashraf Imam


When I first joined the fight against breast cancer nearly 30 years ago, the tools we used were primitive. Mammography was very much in an experimental form and our diagnoses were often flawed. Even the treatments we used then seem primitive by today's standards.

Fortunately, for most women, breast cancer is no longer a death sentence. Improvements in detection, treatment, education and our understanding of the disease have allowed us to take great leaps forward to eradicating it. However, those of us in the field are reminded every day that we are not there yet. In California alone, nearly 20,000 women are diagnosed with breast cancer per year. And more than 4,000 women die from the disease.

complete article at Pasadena Star News

Wide Variation in Mammography Interpretation

The interpretive performance of radiologists reading diagnostic mammograms varies widely due to factors not associated with patient characteristics, according to study findings published in the Dec. 19 issue of the Journal of the National Cancer Institute.

Diana L. Miglioretti, Ph.D., of the Group Health Cooperative in Seattle, and colleagues evaluated 123 radiologists' interpretations of 35,895 diagnostic mammography examinations conducted at 72 facilities from January 1996 through December 2003.

source - RN Web


abstract

2.15.2008

Single Reader With CAD More Efficient, Yields Fewer False Positives, And Possibly More Sensitive Than Double Reading Of Mammograms

Single reading of screening mammograms with computer-aided detection (CAD) is more efficient than double reading and yields a higher sensitivity than the first reader in a double reading program, according to a study conducted by researchers at Charlotte Radiology in Charlotte, NC. In addition, the readings with CAD had a significantly lower recall rate than double reading.

The double reading method consisted of the mammogram being first read by sub-specialized mammographers, with the second reading performed by either a specialist or a general radiologist who is certified in mammography. Single reading with CAD was performed by sub-specialized mammographers.

MedicalNewsToday

Benefits Of Medicare Paid Mammography Lag For Black Women

When Medicare began paying for older women to undergo preventive mammograms in 1991, doctors expected breast cancer mortality rates to drop. Breast cancer deaths did decrease, but new research has unveiled a discrepancy: African American women as a group do not benefit as much as white women.

Breast cancer death rates for the two ethnic groups used to be nearly identical.

"It looks like the implementation of the Medicare benefit did a lot of good, but the benefits may not have accrued to everyone equally. White (death) rates declined faster," said study lead author Dr. Robert Levine, professor in the family and community medicine department at Meharry Medical College in Nashville, Tenn.

MedicalNewsToday

2.14.2008

Aurora® Breast MRI Society Debuts Global Teaching Tool at Society’s Annual Meeting

NORTH ANDOVER, Mass.--(BUSINESS WIRE)--The Aurora® Breast MRI Society, a rapidly growing group of dedicated breast radiologists committed to advancing the use of cutting-edge dedicated breast MRI technology, previewed the newly developed Aurora Breast MRI Society Global PACS Teaching Tool. The teaching tool was introduced before an audience of more than 100 radiology professionals in attendance at the second annual Aurora Breast MRI Society Meeting, recently held in Newport Beach, Calif.

“The establishment of the Aurora Breast MRI Society Global PACS Teaching Tool is incredibly exciting, as it will provide Society members an exclusive Internet-based community in which they are able to network with colleagues, share clinical knowledge and data, enhance professional development, and improve the management and treatment of breast disease,” said Kamilia F. Kozlowski, M.D., president, Aurora Breast MRI Society, and medical director/CEO and clinical breast radiologist, Knoxville Comprehensive Breast Center. “We are proud of the progress made in supporting our Society’s mission through the introduction of the Aurora Breast MRI Society Global PACS Teaching Tool and know that this will be a very valuable tool for all practitioners using it.”

Business Wire

2.13.2008

Computer-Aided Detection in Screening Mammography Enhances Performance of a Single Reader

Large Scale, Historical Controlled Study Finds CAD Increases Sensitivity in
Cancer Detection with Only a Small Increase in Recall Rate

BEDFORD, Mass., Feb. 13 /PRNewswire-FirstCall/ -- Hologic, Inc.
(Nasdaq: HOLX), a diversified medical technologies company
specializing in imaging systems, diagnostics, and interventional
devices dedicated to serving the healthcare needs of women,
today announced the publication of a large scale breast screening
trial comparing a single radiologist using computer- aided detection
(CAD) to double reading without CAD. The author
of the study is Dr. Matthew Gromet of the Breast Imaging Section
of Charlotte Radiology, a large imaging practice (approximately
66,000screening mammograms a year) in Charlotte, North Carolina.

The study(1),published in the on-line version of the American
Journal of Roentgenology, the scientific journal of the American
Roentgen Ray Society, will appear inthe April 2008 issue of the
research journal. The study compared the recall rate, sensitivity,
positive predictive value, and cancer detection rate for
single reading with CAD, versus double reading without CAD. Biopsy
and pathology data for positive cases were also compared.


Source article at
PR Newswire. A copy of this study may be found at:
http://www.ajronline.org/aheadofprint/04_07_2812_WI.pdf

Medipattern's B-CADTM Version 2 Shown To Increase Diagnostic Accuracy By 44% In Lesions Less Than 1 Cm In Size

The Medipattern Corporation (TSX VENTURE:MKI), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making better informed biopsy decisions and to permit a higher standard of care for the millions of patients at risk of cancer, is pleased to announce the publication of a study showing a significant increase in diagnostic accuracy when using B-CAD v2 on lesions less than 1 cm in size (B-CAD v2 is only available outside the United States).

The study was conducted at the PLA301 Hospital in Beijing, PRC and is based upon 100 confirmed biopsied cases, comparing the diagnostic accuracy of three reading scenarios: a single physician, double reading with two physicians and a single physician reading with B-CAD. The accuracy of the single physician increased with B-CAD in all categories. The most striking result shows a statistically significant 44 percent improvement in diagnostic accuracy for the single reader with B-CAD v2 on lesions less than 1 cm in size (n equals 9).

"The Value of Computer-Aided Detection for Breast Ultra-Sonography (B-CAD) in the Diagnosis of Breast Cancer" by Dr. Li and Dr. Xu will be shared at the 18th annual conference of the National Consortium of Breast Centers (NCBC) which takes place March 1 to March 5, 2008 in Las Vegas.

For further information visit MediPattern

2.12.2008

Precancerous Breast Lesions Cause Unnecessary Worry

Carolyn Colwell

TUESDAY, Feb. 12 (HealthDay News) -- Many women diagnosed with a precancerous breast lesion known as ductal carcinoma in situ (DCIS) are highly anxious about their prognosis, even though they face a low risk of a recurrence or of developing invasive breast cancer, a new study finds.

"Many of these women are living as if they're waiting for the other shoe to drop," said lead researcher Dr. Ann Partridge, an oncologist at the Dana-Farber Cancer Institute and Brigham & Women's Hospital, in Boston.

Her team published the findings Feb. 12 in the online edition of the Journal of the National Cancer Institute.

More at Health on the Net Foundation.

Study Finds Patients With Complex Fibroadenomas Can Avoid Surgery

Complex fibroadenomas have a low incidence of malignancy, so women with this condition can be more conservatively treated and avoid surgical biopsy, according to a new study by a team of researchers from the Hadassah-Hebrew University Medical Center in Jerusalem.

A fibroadenoma is a benign growth of the breast that is common in young women. They are not usually associated with breast cancer, and are often diagnosed with simple ultrasound-guided, non-surgical biopsy. Complex fibroadenomas are a subtype of fibroadenomas. They are also benign, but they have calcifications and small cysts that make their pathology more complex than simple fibroadenomas, prompting many doctors to recommend surgical removal to ensure that the fibroadenoma is not malignant.


MedicalNewsToday

2.11.2008

GE Healthcare acquires Image Diagnost International GmbH

GE Healthcare, a unit of General Electric Company (NYSE:GE), announced it has acquired Image Diagnost International GmbH, a provider of information technology (IT) systems used in the diagnosis of breast cancer. Image Diagnost's software offering will expand GE Healthcare's capabilities in breast cancer detection, offering clinicians and national screening services one of the most comprehensive ranges of systems available.

Image Diagnost develops integrated software solutions for mammography workflow and image processing. Digital mammography, first commercialized by GE Healthcare in 1999, brings significant benefits to the diagnosis of breast cancer such as improved cancer detection rates for women with dense breast tissue and ease of use. As the number of hospitals, clinics and screening services using digital mammography increases, there is a significant and growing demand for integrated software solutions to facilitate reporting, storage, sharing and transmission of mammography data.

GE Healthcare

2.09.2008

New Breast Cancer Screening Technology from Fermiscan

By Morgen E. Peck

Fermiscan Holdings, a start-up firm in Sydney, Australia, says it plans to commercialize a ­controversial breast-cancer-screening ­technology that most scientists have given up on. The technology would replace traditional X‑ray mammography with a test requiring just a hair sample—and access to a multimillion-dollar particle accelerator called a synchrotron. Fermiscan is betting that women will greatly prefer offering a hair sample to suffering the discomfort of mammography. Having analyzed 800 hair samples collected from women as they go in for routine breast exams, Fermiscan says it will be ready to start offering screenings by the end of 2008. The trouble is, eight years after the technique was first reported, no independent laboratory has ever been able to make it work.

article atieee spectrum online

2.08.2008

A $10 copay keeps elderly from getting mammogram

By Lex Alexander

GREENSBORO — As little as $10 could be standing between older women and early detection of breast cancer, a new study has found.

The researchers looked at almost 370,000 women ages 65 to 69 in Medicare managed-care plans between 2001 and 2004. They found that women whose plans required copayments of more than $10 were significantly less likely to get mammograms than women who did not have to pay. The gap was even more significant among women of low income or low education.

article at Greensboro News Record

2.06.2008

Fujifilm Introduces Computer Support System for Detecting Breast Cancer

Tokyo, Feb 7, 2008 (JCN) - Fujifilm has announced the FCR Digital Mammography CAD MV-SR657, a computer support system for the detection of breast cancer.

FCR Digital Mammography CAD (Computer Aided Detection) is a computerized detection system to assist physicians in detecting breast cancer through the computer analysis of mammography images taken using FCR (Fuji's own Fuji Computed Radiography system)during routine mammography screening by indicating sites showing the characteristics of breast cancer.

The breasts of Japanese women are generally different from those of Western women in that they often have more developed mammary glands. Fujifilm has developed its proprietary detection algorithm based on a wealth of cases from within Japan, and has been able to achieve a high detection rate for sites indicative of the characteristics of breast cancer, including microcalcifications and masses.

Japan Corporate News

2.04.2008

iCAD Ranks #1 in Mammography CAD User Satisfaction

NASHUA, N.H., Feb. 4 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD - News), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that the Company tops the Mammography CAD market in user satisfaction, according to the independent healthcare research group MD Buyline.

In its 2007 User Satisfaction Report, MD Buyline ranked iCAD #1 in mammography CAD user satisfaction including the company's system performance, system reliability, service response time, applications training, service repair quality, and installation/implementation capabilities as compared to Hologic/R2.

read press release

2.03.2008

Digital mammography best for younger women

Digital mammography was much better than traditional film mammography at spotting breast cancers in younger women or those with dense breasts, US researchers said.

The results confirm earlier findings and better define who will benefit from the newer, more costly digital exams.

Early findings from this same study of 49,528 women published in 2005 suggested that younger women and women with dense breasts would benefit, but also found the digital test was no better than traditional film-based mammography for the overall population of women.

"This paper confirms that if you are under 50, pre- or perimenopausal, and have dense breasts, you should definitely be screened with digital rather than film," Dr Etta Pisano of the University of North Carolina School of Medicine in Chapel Hill said in a statement.

source - YahooXtra News

2.01.2008

Service agencies may be key to increased rural cancer screenings

Hershey, Pa. — Cancer prevention strategies aimed at medically underserved populations may be most successful when they engage trusted community organizations and service providers. A recent Penn State College of Medicine study found that educating women about breast cancer and available screening options at food pantries in rural Indiana County increased the number of free screenings provided to underserved county residents by 28 percent in one year.

For the study, researchers analyzed data from an initiative of the Indiana County Cancer Coalition to determine whether local adaptation of a nationally recognized cancer screening awareness program would improve rates of screening among rural women. The results were published recently in Journal of Rural Health.

Of 302 age-eligible (at least 40 years old) women, 158 had not had a mammogram in the previous year or had not followed up for a subsequent mammogram after an initial finding. The program provided 138 of these women with a mammogram, and for 13 of them, it was their first. Three women were diagnosed with early-stage breast cancer, and all three received treatment.

source - Penn State Live